Racole‑SB 130 Capsules contain Itraconazole IP 130 mg, a broad-spectrum triazole antifungal agent indicated for dermatophytic infections, onychomycosis, histoplasmosis, and other systemic fungal infections. Itraconazole inhibits fungal cytochrome P450 enzyme 14ɑ-demethylase, leading to disrupted ergosterol synthesis and fungal cell membrane dysfunction.
Treats dermatophyte infections like tinea pedis, corporis, and cruris
Effective in fungal nail infections (onychomycosis)
Used for systemic fungal infections including histoplasmosis and blastomycosis (systemic dosing as per guidelines)
High tissue penetration and less frequent dosing improve compliance
Cutaneous fungal infections of skin, hair, or nail
Mucocutaneous candidiasis
Systemic mycoses (prescribed under specialist supervision)
One capsule once daily for 2–4 weeks (skin infections) or up to 12 weeks (nail infections), depending on individual response and physician guidance. Take with food to enhance absorption.
Monitor liver enzymes—avoid in pre-existing hepatic dysfunction
Not recommended with cisapride, quinidine, or other QT‑prolonging drugs
Avoid during pregnancy and breastfeeding
May interact with statins, warfarin, or certain antihistamines
Store at room temperature in original packaging. Keep in a cool, dry place away from children and light.
Racole‑SB 130 offers a high potency, once-daily antifungal option with proven efficacy and convenience—ideal for both superficial and systemic fungal therapy.
